Paul Capital Healthcare Commits $100 Million in Initial Funding to Phase III Development Company S.A.R.L Established to Assist in Management and Funding of Phase III Clinical Trials; Company Announces First Definitive Agreement
1/5/2010 6:32:49 AM
More...
|